Skip to Content

Equaline Sleep Aid Dosage

Generic name: DOXYLAMINE SUCCINATE 25mg
Dosage form: tablet

Medically reviewed on June 4, 2018.

adults and children 12 years of age and over: take one tablet 30 minutes before going to bed; take once daily or as directed by a doctor
children under 12 years of age: do not use

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Equaline Sleep Aid (doxylamine)

Consumer resources

Other brands: Unisom SleepTabs, Sleep Aid, Nighttime Sleepaid

Professional resources

Related treatment guides

Drug Status

Rx
OTC

Availability Rx and/or OTC

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Drug Class

Miscellaneous anxiolytics, sedatives and hypnotics

Related Drugs

Insomnia melatonin, lorazepam, amitriptyline, zolpidem, Ativan, Ambien, More...

Allergies hydroxyzine, Vistaril, levocetirizine, Atarax, Xyzal, doxylamine, More...

Allergic Rhinitis prednisone, Zyrtec, promethazine, fluticasone nasal, loratadine, cetirizine, More...

Conjunctivitis, Allergic prednisone, cetirizine ophthalmic, prednisolone ophthalmic, azelastine ophthalmic, Deltasone, Zaditor, More...

3 more conditions...

Equaline Sleep Aid Rating

No reviews - Add your review

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Nov 1st, 2018), Cerner Multum™ (updated Nov 1st, 2018), Wolters Kluwer™ (updated Oct 31st, 2018) and others. To view content sources and attributions, please refer to our editorial policy.